The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > BUSINESS
BUSINESS
- Denosumab Significantly Reduces Vertebral Fractures in Osteoporosis Patients in PIII Study: Daiichi Sankyo
October 17, 2012
- Asahi Glass Offers CMO Services to Biopharmaceutical Industry Using ASPEX Technology: Dr Kumagai
October 17, 2012
- MediciNova to Bring Japanese Pharma Synthesized Drug Candidates to the World: Dr Matsuda
October 17, 2012
- Qol to Fully Enter CSO Market thru Apo Plus Acquisition, Mr Takada to Be Director
October 16, 2012
- MTPC’s Oral MS Treatment Charging towards Blockbuster Territory
October 16, 2012
- Hospira Files Public Knowledge-Based Application for Generic Gemcitabine for Malignant Lymphoma
October 16, 2012
- Towa Pharmaceutical Expanding Direct-Sales Network as Its Distributors Face Lack of Successors
October 15, 2012
- Pirespa Debuts in South Korea through Ildong: Shionogi
October 15, 2012
- Long-Term Investments in Developing Countries Expects Returns from 2020: President Naito of Eisai
October 15, 2012
- Radical AD Treatments Hit “PIII Wall” Again, but Amyloid β Hypothesis Remains Unshaken
October 15, 2012
- Meiji Seika Pharma to Solely Market 3 Diagnostics for Infectious Diseases
October 12, 2012
- Hisamitsu Posts 4.0% Sales Increase in March-August by Market Share Recovery of Mohrus Tape Series
October 12, 2012
- Eisai to Dissolve, Absorb Its Diagnostics Research Subsidiary Palma Bee’Z
October 12, 2012
- AVEO Files NDA for Tivozanib in US: Astellas
October 12, 2012
- Ajinomoto, Astellas to Codevelop Nateglinide for Combination Use with DPP-4 Inhibitors
October 11, 2012
- MTPC, Kureha Fail to Meet Primary Goal in Global PIII Studies for Kremezin
October 11, 2012
- Kyorin to Transfer Pekiron to Galderma
October 11, 2012
- Sanofi Files Lawsuit against 3 Companies for Approved Allegra Generics
October 11, 2012
- Policy Directions Headed for “Price Cuts for Long-Listed Drugs,” “Price Control for High Priced Drugs”: Prof. Nakamura of Keio Univ.
October 11, 2012
- Lack of Patient Satisfaction with BPH Treatments Offers Opportunity; Can Kissei Get Them to Switch to Urief?
October 11, 2012
ページ
Following the launch of two new therapies since last year, Japan has seen fresh moves in drug development for amyotrophic…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…